Treatment Options for Progressive MS
Significance of Understanding MOAs When Treating MS
Recommendations for Restarting Therapy in MS
Considerations for Using Oral Cladribine in MS
Oral Cladribine Therapy for MS
Newer Therapies in MS: Optimized Care
Appropriateness for Induction Therapy in MS
Early Initiation of DMTs in MS
Surrogate Markers for MS
Diagnostic Tools Used to Identify MS
Early Identification and Diagnosis of MS
Diagnosing MS in the Modern Era
NDA Accepted for SRP-4053 for DMD, MPRI 2.0 Differentiates Parkinson and Progressive Supranuclear Palsy, and Young Donor Plasma Infusion Warning
Neurology News Network for the week of February 23, 2019.
The Mind Wins by a Nose, But the Heart Leads the Way
A recent study evaluated the effect of aerobic exercise on cognitive function and physical conditioning in young adults. The result? These boots are made for more than walking.
Managing Epilepsy: Parting Advice for Neurologists
Potential of Cannabidiol in Epileptic Encephalopathies
Overcoming Adherence Issues in Epileptic Encephalopathies
Optimizing the Care of Patients With Epilepsy
Role of Extended-Release Formulations in Epilepsy
An Overview of the Epilepsy Treatment Paradigm
Parting Advice on Managing Patients With Epilepsy
Stimulation Techniques in Epilepsy: How Do We Choose?
Considerations for Nonmedication Therapy in Epilepsy
Epilepsy: Transitioning From Pediatric to Adult Care
Epilepsy: Recommendations on Discontinuing Therapy
The Cost of Nonadherence in Epilepsy Management
Extended Release Formulation's Role in Treating Epilepsy
Best Practices in Therapy Selection for Epilepsy
Appreciating the Expanding Armamentarium for Epilepsy
Epilepsy Management: Gauging Limitations of Guidelines
